3rd BELSACT Scientific meeting
The upcoming BELSACT meeting will be focused on Cell&Gene Therapy Technologies – Digitilasation and Sustainability. These are topics that are of utmost importance for the evolving Cell&Gene Therapy sector.
Event: Insights into the Belgian framework around CTR / CTIS
Sillar and at.las invite you to join us at the Science Park in Niel for an interactive seminar on February 28th focused on the Belgian framework of CTR, as well the implementation and practical use of CTIS. As of January 31st 2023, sponsors must submit all initial clinical trial applications under the Clinical Trial […]
GATE 2nd Academic-Industrial partnering event
GATE, the U(Z)Gent platform of excellence in Cell and Tissue Engineering, is hosting its second partnering event, bringing academia and industry together for an inspiring afternoon focused on ongoing research within UGent, UZ Gent, imec and VIB. On March 17th they will highlight successful academic-industry partnerships to advance gene and cell therapy programs towards the clinic. […]
Science for health
Science for Health is a yearly event, at which experts are connected around a central theme to promote out-of-the-box thinking and spark new research collaborations. And this year once more, ATMP is the main focus. No surprise therefore that we gladly support this initiative. On November 21st you are welcome to join us in Brussels […]
Advances in Advanced Therapy Manufacture- Amsterdam.
The amc (Advanced therapy medicinal products Manufacturing Community) was formed in 2010 and unites about 400 members who represent cell manufacturing facilities and processes in academia and industry, mostly from the UK. They share ideas and discuss solutions at their bi-annual technical meetings and on Linkedin forum. For the first time they organzing a conference […]
Congratulations to the alumni of the first Summer School ‘GMP in Advanced Therapies’.
Working as an operator in a GMP environment is a challenge. Your succes depends not only on knowledge, but also on a specific skill set and the right attitude. This is even more the case in ATMP, where the pressure on operators is high. During the manufacturing process, operators are confronted with patients’ cell lines, […]
at.las event: “Clinical Development of ATMPs: narrowing the `conversion gap` between clinical trial and go-to market”.
QbD, Venn Life Sciences and at.las invite you to join us on June 13th at the Science Park in Niel to discuss the (pre)clinical development of ATMP’s. The (pre)clinical development of ATMP’s is challenging. We have asked QbD and Venn Life Sciences to get into the hurdles and discuss the solutions. Will be discussed: ATMPs: […]
KNOWLEDGE FOR GROWTH 2022- Ghent.
From May 18th to 19th, Knowledge for Growth is taking place in Ghent. We are happy that Flanders Bio has invited us to host a panel debate. “Advancing CAR-T, a Roundtable on Manufacturing Innovations for the Next Generation.” is the topic of our choice and we have assembled an expert panel, consisting of: Nathalie Cools (anicells) Bie Van […]
Advanced Therapies 2022 – Explore the hottest topics in the ATMP field.
RESEARCH • DEVELOP • COLLABORATE • COMMERCIALISE Early bird registration until December 17th! In May 2022 the annual ATMP congress ‘Advanced Therapies 2022’ is held in London, bringing the most recent and exciting developments in the sector to you. On the agenda : The latest cutting-edge research entering the clinic Safeguarding clinical success Delivering cell […]